| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
1,518 |
1,359 |
$68K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,317 |
1,109 |
$41K |
| J0178 |
Injection, aflibercept, 1 mg |
49 |
40 |
$32K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
1,113 |
890 |
$25K |
| 92134 |
|
2,006 |
1,378 |
$19K |
| 92242 |
|
331 |
301 |
$19K |
| 92250 |
|
911 |
865 |
$13K |
| 92273 |
|
448 |
397 |
$12K |
| J2778 |
Injection, ranibizumab, 0.1 mg |
56 |
45 |
$8K |
| 92226 |
|
777 |
582 |
$7K |
| 92015 |
Determination of refractive state |
568 |
538 |
$7K |
| 92083 |
|
490 |
412 |
$7K |
| 92235 |
|
185 |
161 |
$5K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
207 |
173 |
$5K |
| 92202 |
|
1,021 |
902 |
$4K |
| 92133 |
|
234 |
171 |
$3K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
25 |
25 |
$2K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
48 |
45 |
$897.90 |
| J9035 |
Injection, bevacizumab, 10 mg |
18 |
13 |
$451.00 |